Hypothesis on isolated systolic hypertension in the elderly

Journal of Human Hypertension

Volumn 13, Issue 12, 1999, Pages 813-815

  Safar, M E ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

Antihypertensive therapy; Elderly; Isolated systolic hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; PATHOPHYSIOLOGY; SYSTOLIC HYPERTENSION; VASCULAR ENDOTHELIUM;

EID: 0033398117     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000930     Document Type: Article

References (36)

1. Society of Actuaries, Build and Blood Pressure Study. Chicago III: Society of Actuaries, 1959.
2. Collins R et al. Blood pressure, stroke, and coronary heart disease: Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264.
4. Darne B et al. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989; 13: 392-400.
5. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23: 395-401.
6. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles. Fourth Edition. Arnold Publishing: London, pp 54-113, 201-222, 284-292, 347-401.
7. London GM et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-608.
8. Joannides R et al. Altered nitric oxide pathway in large peripheral arteries of hemodialisis patients. J Hypertens 1996; 14 (Suppl 1): S121 (Abstract 526).
9. Vallance P et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575.
10. De Mey JG, Schiffers PM. Effects of the endothelium on growth responses in arteries. J of Cardiovasc Pharmacol 1993: 21 (Suppl 1): S22-S25.
11. Crow MT, Boluyt MO, Lakatta EG, The molecular and cellular biology of aging in the cardiovascular system. In: Holbrook NJ, Martin GR, Lockshin RA (eds). Cellular aging and cell death, Wiley-Liss Inc: New York, NY, pp 81-107.
12. Glaser E et al. Dynamic versus static compliance of the carotid artery in living wistar-kyoto rats. J Vasc Res 1995; 32: 254-265.
13. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996; 4: 849-853.
14. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endotholium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
15. Laurent S et al. Mechanism of nitrate-induced improvement on arterial compliance depends on vascular territory. J Cardiovasc Pharmacol 1992; 19: 641-649.
16. Simon AC et al. Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment. Am J Cardiol 1979; 44: 505-511.
17. Ghiadoni L et al. Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 1998; 32: 25-32.
18. Tobian L. Salt and hypertension lessons from animals models that relate to human hypertension. Hypertension 1991; 17 (Suppl 1): 152-158.
19. Levy BI et al. Sodium, survival and the mechanical properties of the carotid artery in stroke-prone hypertensive rats. J Hypertens 1997; 15: 251-258.
20. Partovian C, Benetos A, Pommies JP, Safar ME. Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin. Am J Physiol 1998; 274 (Heart Circ Physiol 43): H1423-H1428.
21. Safar ME et al. Sodium, large arteries and diuretic compounds in hypertension. J Hypertens 1992; 10 (Suppl 6): S133-S136.
22. Benetos A, Lacolley P. Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats (SHRs). Arteriosclerosis 1997; 17: 1152-1156.
23. Matrougui K, Schiavi P, Guez D, Henrion D. High sodium intake decreases pressure-induced (myogenic) tone and flow-induced dilatation in resistance arteries from hypertensive rats. Hypertension 1998; 32: 176-179.
24. Benetos A et al. Influence of angiotensin-converting enzyme and angiotensino II type I receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996; 94: 698-703.
25. Benetos A et al. Role of angiotensin II and bradykinin on aortic collagen following converting-enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997; 17: 3196-3201.
26. Simon G, Illyes G. Csiky B. Structural vascular changes in hypertension. Role of angiotensin II, dietary sodium supplementation, blood pressure and time. Hypertension 1998; 32: 654-660.
27. Benetos A et al. Influence of the angiotensine type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 1996; 28: 1081-1084.
28. Pojoga L et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 1998; 11: 856-860.
29. Lacolley P et al. Nitric oxide synthase gene polymorphisms, hood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998; 16: 31-35.
30. Blacher J et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 35: 570-574.
31. Benetos A et al. Pulse pressure: a predictor of long term cardiovascular mortality in a french male population. Hypertension 1997; 30: 1410-1415.
32. Mitchell GF et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation 1997; 96: 4254-4260.
33. Duchier J, Iannascoli F, Safar M. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cordial 1987; 60: 99-102.
34. Staessen JA et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-764.
35. Stampfer MJ et al. Post menopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurse's Health Study. N Engl J Med 1991; 325: 756-762.
36. Corman B et al. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci USA 1998; 95: 1301-1306.